Trust boundary

What has to be true for the read to be verified and stable.

NextConsensus is a specialized measurement system for healthcare claim intelligence. The validation boundary is part of the product.

Four things that have to be true before the read is verified and stable.

Time-Bound Measurement

Every measurement run uses only what was publicly observable at the evaluation timestamp. No future information crosses the boundary. The question at every step: what would have been knowable at the time?

Independent Outcome Labels

Outcome labels — real decisions like FDA label changes, trial holds, safety communications — are sourced from formal public records and stored independently from the measurement pipeline. The pipeline cannot see labels during computation.

Baseline Comparisons

Every validation study compares against explicit baselines: news timing, consensus date, and mention-count benchmarks. The question is not whether the system detected something, but whether it detected something before it was already obvious.

Failure Analysis

Every study includes failure analysis: when the signal was weak, when the claim was unstable, when contestation was insufficient. Uncertainty is preserved, not compressed into false confidence.

The Dismissal Cost Curve.

A claim does not become important because it exists. It becomes important because supporting sources, failed challenges, and wording stabilization accumulate evidence mass. The same dismissal force — a skeptical reviewer, a competing claim, an adverse mention — moves it less over time. We track when a claim becomes costly to dismiss.

A claim grows in mass over time. The same dismissal force produces less displacement as sources accumulate — from large displacement at pre-print stage to negligible after label revision.
The dismissal cost rises as evidence mass accumulates.

The Time-of-Knowability Plane.

Every measurement run answers one question: what was knowable at the evaluation timestamp? A transparent plane divides observable evidence from future events. Everything to the left was knowable. The official event sits to the right. We measure the gap — and never let the future contaminate the past.

A vertical plane divides knowable evidence from future events on a timeline. Evidence dots to the left of the plane are green and visible. Evidence to the right is greyed out. The official event marker sits far to the right, separated by a measurable gap.
Reconstruct what was knowable before the formal event.
Claim Forensics: Illustrative
CLAIM Finerenone / CKD
LANE Phase 1b: Active Audit
VALIDATED 2026-05-04
METHOD v4.2

What is authorized for public claims.

Each measurement lane carries its own independent authorization phase. Stronger public claims require clearing quantitative stability gates in a validated backtest.

finerenone / albuminuric CKD Phase 1b: Active Audit

Threshold transfer statement only; numeric lead-time and holdout claims are frozen pending active production audit

SGLT2 / HF + CKD Phase 1b: Generalized

Threshold transfer statement only

GLP-1 / sarcopenia & lean mass preservation Phase 0: Visible

Seeded visibility replay passed (0.75); no public claims

Radiopharmaceuticals / marrow toxicity Phase 0: Parked

Seeded visibility replay passed (0.55); no public claims

Ex vivo gene editing / off-target durability Phase 0: Parked

Seeded visibility replay passed (0.53); no public claims

All other lanes Phase 0: Frozen

No public claims

  • The validation boundary is part of the product.
  • We do not predict outcomes. We show how the claims behind decisions are changing.
  • Public numeric claims remain frozen until validation gates clear.
  • Exact signal values and promotion criteria are disclosed only inside private briefs.

Action

Request a technical briefing on validation methodology.

One session, scoped to validation architecture and the current authorization posture. Not a sales pitch.

Today's Read finerenone-cardiorenal
Hardening
Signal 0.38 / Gate 0.65
Phase 1b pending review. Other lanes: dossier-build.

Visual Debug

Page:

Width: px

Theme: